Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

In his first address to staffers at HHS since becoming secretary of the department on Feb. 13, Robert F. Kennedy Jr. Tuesday ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...